首頁 > 市場調查報告書 > 製藥

疫苗動物用醫藥

市場調查報告書

商品編碼

1672922

動物抗生素市場按藥物類型、劑型、動物類型和地區分類

Veterinary Antibiotics Market, By Drug Type, By Dosage Form, By Animal Type, By Geography

出版日期: 2025年02月07日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球獸用抗生素市場規模估計為 41.8 億美元，預計到 2032 年將達到 55.1 億美元，2025 年至 2032 年的複合年成長率為 4.0%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	41.8億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	4.00％	2032 年價值預測	55.1億美元

數字。 2025 年動物抗生素市場佔有率（按地區分類）

由於動物保健支出的增加和通用感染疾病的流行，獸用抗生素市場正在經歷顯著成長。畜牧業的發展，特別是已開發地區的畜牧業發展，推動了對抗生素的需求，用於預防和治療伴同性動物的各種感染疾病。此外，生活方式的改變和對富含動物性蛋白質的飲食的日益重視，正在重振世界各地的肉類生產。大規模畜牧生產需要適當使用抗生素來促進肉類動物的生長並預防疾病。

市場動態

牲畜食品消費的增加可能會推動獸用抗生素市場的成長。根據聯合國糧食及農業組織 2019 年的數據，預計 2020 年至 2030 年間全球肉類產量將成長約 15%。然而，畜牧業中抗生素的過度使用和濫用導致了抗生素抗藥性，阻礙了市場的成長。包括噬菌體和益生菌在內的替代治療選擇對市場相關人員來說代表著巨大的機會。開發中國家獸醫保健基礎設施的發展可能在不久的將來為抗生素製造商開闢新的途徑。

本研究的主要特點

本報告對全球獸用抗生素市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2024 年。

它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球動物抗生素市場的主要企業根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行分析。

研究中介紹的主要企業包括 Merck &Co., Inc.、Ceva Sante Animale、Zoetis、Boehringer Ingelheim International GmbH、Dechra Pharmaceuticals、Elanco Animal Health Incorporated、Virbac SA、Bimeda, Inc.、Vetoquinniol、Zydus Corporation Incorporated、Virbac SA、Bimeda, Inc.、Vetoquinniol、Zydus Corporation Abromal、Blackmal Corporation Abrocier Health、Amal。

本報告的見解可以幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球動物抗生素市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過分析全球動物抗生素市場所使用的各種策略矩陣來促進決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 4.18 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.00%	2032 Value Projection:	USD 5.51 Bn

Veterinary antibiotics market has witnessed significant growth due to rising animal healthcare expenditure and increasing prevalence of zoonotic diseases. Growing animal adoption, particularly in developed regions, has also boosted demand for antibiotics to prevent and treat various infections in companion animals. Moreover, changing lifestyles and increasing focus on protein-rich diets from animal sources have revved up meat production across the globe. Large scale livestock production practices necessitate the proper use of antibiotics to promote growth and prevent diseases in animals reared for meat consumption.

Market Dynamics

Rising consumption of livestock-derived food products can drive the veterinary antibiotics market growth. In 2019, according to the United Nations Food and Agriculture Organization, global meat production is projected to grow approximately 15% in the period between 2020 and 2030. However, overuse and misuse of antibiotics in the livestock sector has led to antibiotic resistance, thus, hampering the market growth. Alternative treatment options including bacteriophages and probiotics present significant opportunities for market players. Growing veterinary healthcare infrastructure in developing nations can create new avenues for antibiotics manufacturers in the near future.

Key features of the study

This report provides in-depth analysis of the global veterinary antibiotics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global veterinary antibiotics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck & Co., Inc., Ceva Sante Animale, Zoetis, Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals, Elanco Animal Health Incorporated, Virbac S.A., Bimeda, Inc., Vetoquinol, Zydus Animal Health, Blacksmith Medicines, Inovet, Calier, and Phibro Animal Health Corporation

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global veterinary antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary antibiotics market

Market Segmentation

By Drug Type Insights (Revenue, USD Bn, 2019 - 2032)
- Aminoglycosides
- B-Lactam Antibiotics
- Chloramphenicol
- Fluoroquinolones
- Glycopeptides
- Lincosamides
- Macrolides
- Polymixins
- Tetracyclines
- Others
By Dosage Form Insights (Revenue, USD Bn, 2019 - 2032)
- Powder
- Solutions
- Injections
- Others
By Animal Type Insights (Revenue, USD Bn, 2019 - 2032)
- Companion
- Canine
- Feline
- Livestock
- Bovine
- Ovine
- Porcine
- Others (Poultry, etc.)
Regional Insights (Revenue, USD Bn, 2019 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Merck & Co., Inc.
- Ceva Sante Animale
- Zoetis
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals
- Elanco Animal Health Incorporated
- Virbac S.A.
- Bimeda, Inc.
- Vetoquinol
- Zydus Animal Health
- Blacksmith Medicines
- Inovet
- Calier
- Phibro Animal Health Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Veterinary Antibiotics Market, By Drug Type
- Veterinary Antibiotics Market, By Dosage Form
- Veterinary Antibiotics Market, By Animal Type
- Veterinary Antibiotics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology

4. Veterinary Antibiotics Market, By Drug Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Aminoglycosides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
B-Lactam Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chloramphenicol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fluoroquinolones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Glycopeptides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Lincosamides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Macrolides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Polymixins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Tetracyclines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Veterinary Antibiotics Market, By Dosage Form, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Veterinary Antibiotics Market, By Animal Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Companion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Canine
Feline
Livestock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bovine
Ovine
Porcine
Others (Poultry, etc.)

7. Veterinary Antibiotics Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zoetis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Dechra Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Elanco Animal Health Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Virbac S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bimeda, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vetoquinol
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zydus Animal Health
Blacksmith Medicines
Inovet
Calier
Phibro Animal Health Corporation